The inflammation plays a central pathophysiological role in CIS associated nephrotoxicity, as CIS injection induces a cascade of inflammatory responses in the kidney through the release of several cytokines (TNF-α, IL-1β etc.)and chemokines [MCP-1, macrophage inflammatory protein (MIP)-2 etc.]. Here, IL1B is linked to in situ carcinoma.